Clin2
NCT06666790Likely a fitRecruiting

DermaSensor device study for suspicious skin spots

Melanoma, Skin

Part of Cancer, Skin clinical trials.

This study is testing a handheld device that scans skin lesions to help detect melanoma. If you have a spot that your doctor thinks could be melanoma, this study will see how well the device works compared to standard checks.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
396 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You are 40 years old or older.
  • You have a skin spot that your doctor thinks might be melanoma.
  • The spot can be reached by a small handheld scanner (not inside ears, under nails, or on the soles of your feet).
  • The spot is not on or near scars, cuts, or areas that have been biopsied before.
  • The spot is 2.5mm to 15mm across (about the size of a pencil eraser).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06788665Not yet recruiting
Testing a device that measures melanoma depth from photos

This study tests a device that takes a close-up picture of a suspicious mole to estimate how deep the melanoma is before surgery. This might help doctors plan surgery more accurately.

Gothenburg
NCT06661577Not yet recruiting
Study of a new skin scanner for skin conditions

This study tests a new device called LumAssure that scans skin to help doctors look at skin conditions. It aims to see if the device works well for people with different skin issues.

Auckland
NCT07201376Recruiting
Testing a skin imaging device for non-melanoma skin cancer

This study tests a device that uses a special light to image skin lesions after applying an FDA-approved cream. It aims to see if the device can help doctors see benign skin growths more clearly before they are removed.

Lebanon, New Hampshire
NCT06782399Enrolling by invitation· Early Phase 1
Drug screening for skin squamous cell cancer lesions

This trial tests a device placed on skin cancer lesions to see which drugs might work best. It is for people with visible squamous cell carcinoma on the skin, including lesions that have come back after radiation.

Boston, Massachusetts
NCT07863076Recruiting
Skin spot patterns seen with a special camera

This study looks at different types of pigmented skin spots using a special camera (dermoscopy) and lab tests. It aims to help doctors better tell harmless spots from serious ones, like melanoma.

Sohag
NCT06064019Recruiting
Using Nevisense to help diagnose skin cancer

This study tests a device called Nevisense that helps doctors check if a suspicious skin spot is a type of skin cancer called keratinocyte cancer (including basal cell carcinoma, squamous cell carcinoma, and related conditions like actinic keratosis). If you have a spot that your doctor is unsure about, this tool may help get a clearer answer.

Wuppertal

Hear when a new Melanoma (Skin) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.